DE69925116D1 - Neue, physiologisch aktive peptide und ihre verwendung. - Google Patents
Neue, physiologisch aktive peptide und ihre verwendung.Info
- Publication number
- DE69925116D1 DE69925116D1 DE69925116T DE69925116T DE69925116D1 DE 69925116 D1 DE69925116 D1 DE 69925116D1 DE 69925116 T DE69925116 T DE 69925116T DE 69925116 T DE69925116 T DE 69925116T DE 69925116 D1 DE69925116 D1 DE 69925116D1
- Authority
- DE
- Germany
- Prior art keywords
- seq
- amino acid
- acid sequence
- development
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 102000005962 receptors Human genes 0.000 abstract 2
- 108020003175 receptors Proteins 0.000 abstract 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 230000036528 appetite Effects 0.000 abstract 1
- 235000019789 appetite Nutrition 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000006386 memory function Effects 0.000 abstract 1
- 230000004220 muscle function Effects 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 238000001525 receptor binding assay Methods 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 210000002027 skeletal muscle Anatomy 0.000 abstract 1
- 230000002381 testicular Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP7813998 | 1998-03-25 | ||
| JP7813998 | 1998-03-25 | ||
| JP26697298 | 1998-09-21 | ||
| JP26697298 | 1998-09-21 | ||
| PCT/JP1999/001482 WO1999048920A1 (en) | 1998-03-25 | 1999-03-24 | Novel physiologically active peptides and utilization thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69925116D1 true DE69925116D1 (de) | 2005-06-09 |
| DE69925116T2 DE69925116T2 (de) | 2005-11-17 |
Family
ID=26419215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69925116T Expired - Lifetime DE69925116T2 (de) | 1998-03-25 | 1999-03-24 | Neue, physiologisch aktive peptide und ihre verwendung. |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7064181B1 (de) |
| EP (1) | EP1065214B1 (de) |
| AT (1) | ATE294816T1 (de) |
| AU (1) | AU2957099A (de) |
| CA (1) | CA2323503C (de) |
| DE (1) | DE69925116T2 (de) |
| WO (1) | WO1999048920A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7876700A (en) * | 1999-10-12 | 2001-04-23 | Lexicon Genetics Incorporated | Human galanin family proteins and polynucleotides encoding the same |
| EP1275659A4 (de) * | 2000-04-11 | 2004-05-19 | Takeda Chemical Industries Ltd | Physiologisch aktive peptide und anwendung derselben |
| WO2002066064A1 (en) * | 2001-01-19 | 2002-08-29 | Takeda Chemical Industries, Ltd. | Use of galanin-like peptide |
| RU2177802C1 (ru) * | 2001-01-25 | 2002-01-10 | Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" | Тетрапептид, регулирующий функции предстательной железы, фармакологическое средство на его основе и способ его применения |
| US7736654B2 (en) | 2001-04-10 | 2010-06-15 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| EP1437367A4 (de) | 2001-09-26 | 2005-01-26 | Takeda Pharmaceutical | Antikörper und dessen verwendung |
| WO2003070950A1 (fr) * | 2002-02-22 | 2003-08-28 | Takeda Chemical Industries, Ltd. | Nouvel adn et utilisation correspondante |
| US7642281B2 (en) * | 2002-08-07 | 2010-01-05 | Helicon Therapeutics, Inc. | Indolone compounds useful to treat cognitive impairment |
| AU2005299771A1 (en) * | 2004-10-21 | 2006-05-04 | High Point Pharmaceuticals, Llc | Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use |
| US20090317395A1 (en) * | 2006-07-11 | 2009-12-24 | Barbara Kofler | Antimicrobial Peptide Derived from Galanin Message Associated Peptide (GMAP) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992012997A1 (en) | 1991-01-16 | 1992-08-06 | The General Hospital Corporation | Human galanin |
| US5576296A (en) * | 1991-05-15 | 1996-11-19 | Aktiebolaget Astra | Galanin antagonist |
| SE9101472D0 (sv) | 1991-05-15 | 1991-05-15 | Trion Forskning & Utveckling | Galanin antagonist |
-
1999
- 1999-03-24 WO PCT/JP1999/001482 patent/WO1999048920A1/ja not_active Ceased
- 1999-03-24 AU AU29570/99A patent/AU2957099A/en not_active Abandoned
- 1999-03-24 AT AT99910677T patent/ATE294816T1/de not_active IP Right Cessation
- 1999-03-24 CA CA2323503A patent/CA2323503C/en not_active Expired - Fee Related
- 1999-03-24 EP EP99910677A patent/EP1065214B1/de not_active Expired - Lifetime
- 1999-03-24 US US09/646,078 patent/US7064181B1/en not_active Expired - Fee Related
- 1999-03-24 DE DE69925116T patent/DE69925116T2/de not_active Expired - Lifetime
-
2006
- 2006-03-15 US US11/376,694 patent/US7374910B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1065214A4 (de) | 2003-03-12 |
| ATE294816T1 (de) | 2005-05-15 |
| DE69925116T2 (de) | 2005-11-17 |
| EP1065214B1 (de) | 2005-05-04 |
| US7064181B1 (en) | 2006-06-20 |
| CA2323503A1 (en) | 1999-09-30 |
| WO1999048920A1 (en) | 1999-09-30 |
| US20060155109A1 (en) | 2006-07-13 |
| AU2957099A (en) | 1999-10-18 |
| EP1065214A1 (de) | 2001-01-03 |
| CA2323503C (en) | 2010-09-28 |
| US7374910B2 (en) | 2008-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1717315A3 (de) | Osteoprotegerin bindende Proteine und Rezeptoren | |
| ATE257160T1 (de) | Peptidsequenzen als scharnierregionen in proteinen wie immunglobulinfragmenten und ihre verwendung in der heilkunde | |
| DE69535641D1 (de) | Morphogene protein-spezifische zelloberflächenrezeptoren und ihre verwendungen | |
| NO964650D0 (no) | LAG-3 protein-opplöselige polypeptidfraksjoner, fremgangsmåte for fremstilling, teraupeutisk preparat og anti-idiotype antistoff | |
| EP2311955A3 (de) | Osteoprotegerin bindende Proteine und deren Rezeptoren | |
| ATE342359T1 (de) | Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften | |
| EP2540309A3 (de) | Gewebeschützende Peptide und ihre Verwendung | |
| ATE382055T1 (de) | Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren | |
| NO20074516L (no) | Pattedyrcytokinlignende polypeptid-1 | |
| JP2000312590A5 (de) | ||
| ATE368053T1 (de) | Antimikrobielle peptide | |
| WO2002002627A3 (en) | Interferon-like protein zcyto21 | |
| DE69939327D1 (de) | Funktionelle antagonisten von hedgehog-aktivität | |
| DE69925116D1 (de) | Neue, physiologisch aktive peptide und ihre verwendung. | |
| GB9722320D0 (en) | Human cell cycle checkpoint proteins | |
| ATE542138T1 (de) | Her-2-bindungsantagonisten | |
| DE69926627D1 (de) | Insulinartigen wachstumsfaktor bindendes protein -3 variante | |
| ATE190318T1 (de) | Pcna bindende substanz | |
| NO20005081D0 (no) | Et polypeptid inneholdende aminosyren fra et N-terminalt kolinbindende protein A-truncat, vaksine avledet derfra og anvendelser derav | |
| ATE291033T1 (de) | Therapeutische peptide | |
| AU2676399A (en) | Novel cystine knot protein and materials and methods for making it | |
| ATE366810T1 (de) | Menschliche p51-gene und deren genprodukte | |
| BR0108376A (pt) | Composto, polepeptìdeo, ácido nucleico, vetor, vìrus recombinante defectivo, anticorpo ou fragmento ou derivado de anticorpo, composição farmacêutica, processos para a seleção ou a caracterização de moléculas ativas e para a produção de um composto peptìdico, proteìna, célula, e, mamìfero não-humano | |
| DE60325227D1 (de) | ||
| JP2002335976A5 (de) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |